Todd C W, Goodgame R W, Colley D G
Am J Trop Med Hyg. 1980 Sep;29(5):875-81.
The lymphocyte blastogenic responses of chronic schistosomiasis mansoni patients were tested in vitro in medium supplemented with either normal human serum or patients' serum (either autologous or third party). As expected, when patients' lymphocytes were cultured in patient sera, many of them (75--78%) displayed reduced responsiveness to schistosome antigens (derived from either the cercariae, adult worms or eggs of Schistosoma mansoni), but not to Candida albicans extract. For decreased blastogenesis to be manifest, a combination of both suppressive sera and suppressible cells was required; however, some patients had nonsuppressible cells and not all sera were suppressive. In an attempt at classification, four categories of patient responsiveness concerning serosuppression are proposed. The categories depend on the suppressive capabilities of patient sera and the response of patient lymphocytes to suppressive sera. By individually testing the capabilities of each patient's lymphocytes and sera in relationship to each antigenic preparation, we were able to assign the majority of patient responses to a given category. It is hoped that by using these categories, a better understanding of the mechanisms concerning serosuppression will be obtained.
在添加了正常人血清或患者血清(自体血清或第三方血清)的培养基中,对慢性曼氏血吸虫病患者的淋巴细胞体外增殖反应进行了检测。正如预期的那样,当患者的淋巴细胞在患者血清中培养时,其中许多细胞(75%-78%)对血吸虫抗原(源自曼氏血吸虫的尾蚴、成虫或虫卵)的反应性降低,但对白色念珠菌提取物的反应性未降低。要表现出增殖反应降低,需要抑制性血清和可被抑制的细胞同时存在;然而,一些患者有不可被抑制的细胞,而且并非所有血清都具有抑制作用。为了进行分类,提出了关于血清抑制的四类患者反应性。这些类别取决于患者血清的抑制能力以及患者淋巴细胞对抑制性血清的反应。通过分别检测每位患者的淋巴细胞和血清与每种抗原制剂相关的能力,我们能够将大多数患者的反应归入某一给定类别。希望通过使用这些类别,能够更好地理解血清抑制的机制。